Noninvasive measurement of phenylalanine by iontophoretic extraction in patients with phenylketonuria

Journal of Inherited Metabolic Disease

Volumn 30, Issue 6, 2007, Pages 910-915

  Longo, Nicola ^a   Li, S K ^b,d   Yan, G ^c   Kochambilli, R P ^b   Papangkorn, K ^b   Berglund, D ^c   Ghanem, A H ^c   Ashurst, C L ^a   Ernst, S L ^a   Pasquali, M ^a   Higuchi, W I ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Aciont Inc   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; IONTOPHORESIS; NON INVASIVE MEASUREMENT; PATIENT MONITORING; PHENYLKETONURIA; TANDEM MASS SPECTROMETRY;

BIOLOGICAL TRANSPORT; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EQUIPMENT DESIGN; HUMANS; IONTOPHORESIS; MASS SPECTROMETRY; PHENYLALANINE; PHENYLKETONURIAS; REPRODUCIBILITY OF RESULTS; SKIN;

EID: 37249064751     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-007-0675-y     Document Type: Article

References (11)

1. Degim IT, Ilbasmis S, Dundaroz R, Oguz Y (2003) Reverse iontophoresis: A non-invasive technique for measuring blood urea level. Pediatr Nephrol 18 (10): 1032-1037.
2. Delgado-Charro MB, Guy RH (2003) Transdermal reverse iontophoresis of valproate: A noninvasive method for therapeutic drug monitoring. Pharm Res 20 (9): 1508-1513.
3. Huang T, Warsinke A, Kuwana T, Scheller FW (1998) Determination of l-phenylalanine based on an NADH-detecting biosensor. Anal Chem 70 (5): 991-997.
4. Li SK, Higuchi WI, Zhu H, Kern SE, Miller DJ, Hastings MS (2003) In vitro and in vivo comparisons of constant resistance AC iontophoresis and DC iontophoresis. J Control Release 91 (3): 327-343.
5. Longo N (2004) Inherited disorders of amino acid metabolism presenting in adults. In: Kasper D, Braunwald E, Fauci A, et al, eds. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 2331-2334.
6. Mackey SA, Berlin CM Jr (1992) Effect of dietary aspartame on plasma concentrations of phenylalanine and tyrosine in normal and homozygous phenylketonuric patients. Clin Pediatr (Phila) 31 (7): 394-399.
7. Merino V, Lopez A, Hochstrasser D, Guy RH (1999) Noninvasive sampling of phenylalanine by reverse iontophoresis. J Control Release 61 (1-2): 65-69.
8. Potts RO, Tamada JA, Tierney MJ (2002) Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev 18 (Supplement 1): S49-53.
9. Schweitzer-Krantz S, Burgard P (2000) Survey of national guidelines for the treatment of phenylketonuria. Eur J Pediatr 159 (Supplement 2): S70-73.
10. Surtees R, Blau N (2000) The neurochemistry of phenylketonuria. Eur J Pediatr 159 (Supplement 2): S109-113.
11. Yan G, Higuchi WI, Szabo A, Li SK (2004) Correlation of transdermal iontophoretic phenylalanine and mannitol transport: Test of the internal standard concept under DC iontophoresis and constant resistance AC iontophoresis conditions. J Control Release 98 (1): 127-138.